ع
DOC Medical Center said in an announcement that it had recognised two separate milestones with the first anniversary of its Izghawa branch and the completion of 5,000 MBST treatment sessions across all its facilities. The Izghawa branch anniversary event took place on October 3, 2026 at Edge La Plaza in partnership with Nabina Medical Group, which has served as the master licensee for MBST technology across the GCC since the branch opened in late 2025. The centre operates as Qatar’s flagship location for the German-developed therapy that applies low-energy electromagnetic fields to stimulate cellular repair in musculoskeletal conditions.
The Izghawa facility delivers orthopaedic, rehabilitation and internal medicine services, with the latter led by Dr. Myadah Afadar who has emphasised close collaboration across departments to address chronic conditions comprehensively. MBST, formally known as Molecular Biophysical Stimulation, provides a non-invasive alternative for patients suffering from chronic pain, arthritis, osteoporosis, sports injuries and degenerative diseases. According to the centre’s assessment the dual milestones demonstrate increasing adoption of regenerative approaches that aim to reduce reliance on surgery or long-term medication.
Mansoor Nabina, CEO of Nabina Medical Group, described the 5,000-session milestone as an important achievement for the joint venture and reaffirmed the shared goal of broadening access to MBST technology in Qatar and the wider Arab region. Dr. Fooladi, medical director of the Izghawa branch, credited the results to effective teamwork, specialised staff training and tightly coordinated patient care pathways. Rabih Abouhalka, marketing strategist at DOC Medical Center, pointed to the contribution of targeted outreach in raising awareness and building stronger community links around the available services.
The Izghawa branch was established through a joint venture that positioned Qatar as an emerging hub for regenerative medicine in the GCC, aligning with priorities outlined in Qatar National Vision 2030 for health innovation and diversified economic development. A study published by Emergen Research placed the broader Middle East stem cell and regenerative therapy market at $1.2 billion in 2024, with projections for growth to $3.5 billion by 2034 at a compound annual rate of 11.5 percent. The therapy’s focus on evidence-based, non-invasive protocols has drawn interest from patients seeking alternatives to conventional orthopaedic interventions.
MBST technology originated from principles used in MRI imaging but applies controlled magnetic resonance to enhance tissue regeneration at the cellular level rather than for diagnostic purposes. The 5,000-session total reflects activity across all DOC Medical Center locations and remains distinct from the branch-specific anniversary celebration. Officials noted that internal medicine integration at Izghawa has allowed more holistic management of age-related and degenerative conditions prevalent in the population.
Nabina Medical Group has indicated that the Izghawa centre forms the cornerstone of wider regional rollout plans extending into Africa, though specific timelines for additional sites were not disclosed in the latest update. The partnership continues to monitor patient outcomes to refine protocols and support clinical data collection on long-term efficacy. Investment in such advanced therapeutic infrastructure reflects Qatar’s ongoing commitment to elevating its healthcare sector through international collaborations and technology transfer.
